Wednesday, 6 August 2014

7, August 2014

Interval walking healthier than continuous walking for diabetics

A new research has demonstrated that training with alternating levels of walking intensity i.e. interval training can be better than walking at a continuous speed that will ultimately help manage blood sugar in people with type 2 diabetes. The research conducted by Dr Thomas Solomon, University of Copenhagen, Denmark, and colleagues showed that effects of exercise on blood sugar (glycaemic) control in individuals with type 2 diabetes were well documented but the optimal exercise intensity and type remained to be defined.
The researchers found that improved blood sugar control was only evident in the interval-walking training (IWT), group, and this was likely to be caused by IWT-induced increased in insulin sensitivity and increased peripheral glucose disposal, indicative of improved glucose metabolism No changes occurred in the continuous-walking training (CWT) or CON groups.  
The authors asserted that the most important finding of this study was that IWT, but not CWT, increased insulin sensitivity without a compensatory decrease in insulin secretion, which improvied the overall impact of insulin on blood sugar in these patients. The study is published in Diabetologia (the journal of the European Association for the Study of Diabetes).  

07.08.2014









Why is drug-resistant TB such a big challenge for India?

The biggest challenge for India is to treat drug resistant tuberculosis (TB), a health ministry official said Wednesday. ‘How we treat drug resistant TB is going to be the major challenge for India,’ Lov Verma, secretary, Department of Health and Family Welfare, said. Echoing this, World Health Organisation (WHO) representative Nata Menabde said: ‘Drug reisitant TB is the major area on which the government has to concentrate in the future. The facilities available for such kind of TB are not adequate.’
Drug resistant TB is defined as one that is resistant to least isoniazid (INH) and rifampicin(RMP) – the two most powerful first-line treatment anti-TB drugs. As per the Global Tuberculosis Report 2013 of WHO, India has the highest number of multi-drug-resistant TB patients. The two officials were speaking here at the launch of ASSOCHAM’s report ‘Tuberculosis awareness prevention and wellness program: Getting to zero death’.   
With India having about 2.2 million cases of TB, experts, however, highlighted that it would take more than a decade to achieve zero-death target for TB. ‘With India having 26 percent of global TB cases, new approaches need to be undertaken to make this an achievable goal. There has to be improvement in social determinants like housing and social environment to prevent new cases from emerging,’ added Menabde.
John Beed, mission director, United States Agency for International Development(USAID), also added that it is going to take concerted ten years to achieve zero TB deaths. ‘..but setting that goal becomes important. The scale and diversity of India is unmatched anywhere so the country has to look at trying to scale the programme and look at the project being run by public sector and also ensure a joint collaboration with private sector,’ said Beed. The official from Associated Chambers of Commerce and Industry of India (ASSOCHAM) assured that they will involve private stakeholders for awareness and preventive healthcare for TB.   
07.08.2014








Don’t waste words on people who deserve your silence


No comments:

Post a Comment